Literature DB >> 10465304

Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.

A Franzén1, E Piek, B Westermark, P ten Dijke, N E Heldin.   

Abstract

Thyroid growth and function are intricately regulated by both positive and negative factors. In the present study, we have investigated the expression of transforming growth factor-beta (TGF-beta) super-family members and their receptors in normal porcine thyroid follicle cells. In tissue sections of porcine thyroids, we observed an expression of TGF-beta1, activin A, and bone morphogenetic protein (BMP)-7 proteins. The staining was localized to the follicular epithelium. In affinity cross-linking experiments, TGF-beta1 was found to bind to heteromeric complexes of TGF-beta type I and type II receptors, and activin A bound most efficiently to heteromeric complexes of activin type IB and type II receptors. We were unable to detect any BMP receptors (BMPRs) in attempts to perform affinity cross-linking with BMP-7. However, expression of BMPR-IA and BMPR-II messenger RNA (mRNA) was detected by Northern blot analysis. Both TGF-beta1 and activin A, but not BMP-7, increased the phosphorylation of Smad2, induced nuclear translocation of Smad2, Smad3, and Smad4, and inhibited thyrocyte cell growth as well as TSH-stimulated cAMP response. TGF-beta1 was more potent, compared with activin A, to induce these cellular responses. Taken together, our findings indicate a role for several members of the TGF-beta family in regulation of thyroid growth and function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10465304     DOI: 10.1210/endo.140.9.6961

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  In vitro release of activin A from human normal and pathological thyroid tissues.

Authors:  P S Morpurgo; A Corsi; S Corbetta; L Vicentini; A Spada
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

2.  Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21.

Authors:  J D McKay; F Lesueur; L Jonard; A Pastore; J Williamson; L Hoffman; J Burgess; A Duffield; M Papotti; M Stark; H Sobol; B Maes; A Murat; H Kääriäinen; M Bertholon-Grégoire; M Zini; M A Rossing; M E Toubert; F Bonichon; M Cavarec; A M Bernard; A Boneu; F Leprat; O Haas; C Lasset; M Schlumberger; F Canzian; D E Goldgar; G Romeo
Journal:  Am J Hum Genet       Date:  2001-07-02       Impact factor: 11.025

3.  Reversible increase of serum activin A levels in women with Graves' disease.

Authors:  M Centanni; N Viceconti; S Luisi; F M Reis; L Gargano; F Maiani; A Franchi; G Canettieri; F Petraglia
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

4.  TGF-β promotes proliferation of thyroid epithelial cells in IFN-γ(-/-) mice by down-regulation of p21 and p27 via AKT pathway.

Authors:  Yujiang Fang; Shiguang Yu; Helen Braley-Mullen
Journal:  Am J Pathol       Date:  2011-11-24       Impact factor: 4.307

5.  TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma.

Authors:  C Eloy; J Santos; J Cameselle-Teijeiro; P Soares; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  2012-04-20       Impact factor: 4.064

6.  Activin signaling: effects on body composition and mitochondrial energy metabolism.

Authors:  Liunan Li; Joseph J Shen; Juan C Bournat; Lihua Huang; Abanti Chattopadhyay; Zhihong Li; Chad Shaw; Brett H Graham; Chester W Brown
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

7.  Influence of signal transducer and activator of transcription-1 signaling on thyroid morphology and function.

Authors:  Hiroaki J Kimura; Roberto Rocchi; Melissa A Landek-Salgado; Koichi Suzuki; Cindy Y Chen; Miho Kimura; Noel R Rose; Patrizio Caturegli
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

8.  Mediator complex subunit 16 is down-regulated in papillary thyroid cancer, leading to increased transforming growth factor-β signaling and radioiodine resistance.

Authors:  Hongwei Gao; Peirong Bai; Lin Xiao; Mengjia Shen; Qiuxiao Yu; Yuanyuan Lei; Wenting Huang; Xiang Lin; Xinyi Zheng; Tao Wei; Yong Jiang; Feng Ye; Hong Bu
Journal:  J Biol Chem       Date:  2020-06-12       Impact factor: 5.157

9.  Acceleration of BRAFV600E-induced thyroid carcinogenesis by TGFβ signal deficiency in mice.

Authors:  Mika Shimamura; Tomomi Kurashige; Rassul Kuatov; Masahiro Nakashima; Yuji Nagayama
Journal:  Endocrine       Date:  2020-04-12       Impact factor: 3.633

10.  Effects of the Smad4 C324Y mutation on thyroid cell proliferation.

Authors:  Sonia D'Inzeo; Arianna Nicolussi; Francesco Nardi; Anna Coppa
Journal:  Int J Oncol       Date:  2013-04-17       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.